Stockreport

MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy

MAIA Biotechnology, Inc.  (MAIA) 
PDF Manuscript featured in leading open-access peer-reviewed scientific journal Nucleic Acids Research CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: [Read more]